Dr. Yamamoto specializes in virology and infectious
disease medicine. He earned Ph.D. from Department of Molecular Virology, Graduate
School of Tokyo Medical and Dental University. He served as a researcher and a
medical doctor at National Institute of Infectious Diseases and Tokyo Medical
and Dental University. As part of projects related to The Institute of Oriental
Philosophy, Dr. Yamamoto contributed his article to Daijo Bukkyo no Chousen [A Challenge for Mahayana Buddhism] (2010)
and had charge of a open class organized by University of Hachioji College
Community.
In his lecture, Dr. Yamamoto first outlined the
Buddhist view of life from the standpoint of ‘Ten Worlds’, ‘nine
consciousnesses’ and ‘dependent origination’. He stressed that all life
represents fundamental life of the universe and possesses the ultimate life of
Buddha. Touching upon the bioethical issues in modern medicine, he explained
about embryonic
stem (ES) cells and induced pluripotent
stem (iPS) cells for ‘regenerative medicine’ through his own research.
He listed up ethical questions by each stage of
making cells such as ‘Can we regard a fertilized embryo as equal to a complete
human?’ and ‘For the purpose of study, can we utilize extra embryo left in the
process of reproductive medicine?’ Then, he categorized these questions into
three from the Buddhist viewpoint: 1) human dignity and use of human life, 2)
beginning of human life and 3) diversity of human life and the identity.
Based on above viewpoints, he remarked, “If human
life is regarded as the ultimate, naturally, human life should not be utilized
for the certain purpose. While it is hard to fix the moment that human life
begins in the ontogenetic process, embryonic dignity should be taken into
consideration as the embryo has a potential of life.”
Organizer: The Institute of Oriental Philosophy
Lecturer: Dr. Norio Yamamoto (Commissioned
Researcher, The Institute of Oriental Philosophy / Associate Professor, Juntendo University)
Venue: TKP Ichigaya Conference
Center (Shinjuku Ward, Tokyo)
Date: November 30, 2017
|
|